(-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of APOD mRNA CTD PMID:23649840 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of APOD mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol multiple interactions ISO RGD:2137 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOD mRNA CTD PMID:32741896 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of APOD mRNA CTD PMID:16514628 , PMID:26921789 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of APOD mRNA CTD PMID:19619570 17beta-estradiol 3-benzoate multiple interactions ISO RGD:2137 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOD mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10180 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:10180 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of APOD mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10180 6480464 Tetrachlorodibenzodioxin results in decreased expression of APOD mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2137 6480464 Tetrachlorodibenzodioxin results in decreased expression of APOD mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of APOD mRNA CTD PMID:19619570 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:2137 6480464 2 more ... CTD PMID:32109520 2-acetamidofluorene decreases expression ISO RGD:10180 6480464 2-Acetylaminofluorene results in decreased expression of APOD mRNA CTD PMID:20713471 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:10180 6480464 tetrabromobisphenol A results in decreased expression of APOD mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of APOD mRNA CTD PMID:28628672 3-methyladenine affects localization EXP 6480464 3-methyladenine affects the localization of APOD protein CTD PMID:28182653 3-methylcholanthrene decreases expression ISO RGD:10180 6480464 Methylcholanthrene results in decreased expression of APOD mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression ISO RGD:10180 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of APOD mRNA CTD PMID:30951980 4-hydroxynon-2-enal decreases abundance ISO RGD:10180 6480464 APOD protein results in decreased abundance of 4-hydroxy-2-nonenal CTD PMID:28182653 4-hydroxyphenyl retinamide increases expression ISO RGD:10180 6480464 Fenretinide results in increased expression of APOD mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 [Decitabine co-treated with trichostatin A] affects the expression of APOD mRNA CTD PMID:16865689 6-propyl-2-thiouracil decreases expression ISO RGD:2137 6480464 Propylthiouracil results in decreased expression of APOD mRNA CTD PMID:24780913 , PMID:25825206 8-anilinonaphthalene-1-sulfonic acid affects binding EXP 6480464 1-anilino-8-naphthalenesulfonate binds to APOD protein CTD PMID:16461020 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of APOD mRNA CTD PMID:32763439 afimoxifene increases expression EXP 6480464 afimoxifene results in increased expression of APOD mRNA CTD PMID:16514628 aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of APOD gene, Aflatoxin B1 results in increased methylation of APOD intron CTD PMID:27153756 , PMID:30157460 Aflatoxin B2 alpha decreases methylation EXP 6480464 aflatoxin B2 results in decreased methylation of APOD intron CTD PMID:30157460 alachlor affects expression ISO RGD:2137 6480464 alachlor affects the expression of APOD mRNA CTD PMID:19425180 all-trans-4-oxoretinoic acid increases expression EXP 6480464 4-oxoretinoic acid results in increased expression of APOD mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of APOD mRNA CTD PMID:15982314 all-trans-retinoic acid affects binding EXP 6480464 APOD protein binds to Tretinoin CTD PMID:28182653 all-trans-retinol affects binding EXP 6480464 Vitamin A binds to APOD protein CTD PMID:16461020 ammonium chloride affects expression ISO RGD:2137 6480464 Ammonium Chloride affects the expression of APOD mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Paraquat results in increased expression of APOD mRNA], pyrazolanthrone inhibits the reaction [Paraquat results in increased expression of APOD protein] CTD PMID:21688324 benzo[a]pyrene decreases expression ISO RGD:10180 6480464 Benzo(a)pyrene results in decreased expression of APOD mRNA CTD PMID:20713471 benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of APOD intron CTD PMID:30157460 benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of APOD exon CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10180 6480464 Benzo(a)pyrene results in increased expression of APOD mRNA CTD PMID:27195522 benzo[e]pyrene increases methylation EXP 6480464 benzo(e)pyrene results in increased methylation of APOD intron CTD PMID:30157460 bexarotene increases expression ISO RGD:10180 6480464 bexarotene results in increased expression of APOD mRNA CTD PMID:17849452 bisphenol A decreases expression ISO RGD:2137 6480464 bisphenol A results in decreased expression of APOD mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of APOD mRNA CTD PMID:31715268 bisphenol A increases expression ISO RGD:10180 6480464 bisphenol A results in increased expression of APOD mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:10180 6480464 bisphenol F results in increased expression of APOD mRNA CTD PMID:30951980 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of APOD mRNA CTD PMID:29741670 cadmium dichloride increases methylation ISO RGD:2137 6480464 Cadmium Chloride results in increased methylation of APOD promoter CTD PMID:22457795 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of APOD mRNA CTD PMID:29741670 carbon nanotube increases expression ISO RGD:10180 6480464 Nanotubes more ... CTD PMID:25554681 chloroquine affects localization EXP 6480464 Chloroquine affects the localization of APOD protein CTD PMID:28182653 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of APOD mRNA CTD PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of APOD mRNA CTD PMID:27392435 clozapine increases expression ISO RGD:10180 6480464 Clozapine results in increased expression of APOD mRNA, Clozapine results in increased expression of APOD protein CTD PMID:11158250 more ... copper atom affects binding EXP 6480464 APOD protein binds to Copper CTD PMID:23896426 copper(0) affects binding EXP 6480464 APOD protein binds to Copper CTD PMID:23896426 coumestrol decreases expression EXP 6480464 Coumestrol results in decreased expression of APOD mRNA CTD PMID:19167446 Cuprizon decreases expression ISO RGD:2137 6480464 Cuprizone results in decreased expression of APOD mRNA CTD PMID:26577399 , PMID:27523638 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of APOD mRNA CTD PMID:28628672 dibenz[a,h]anthracene increases expression ISO RGD:10180 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:2137 6480464 Dibutyl Phthalate results in increased expression of APOD mRNA CTD PMID:21266533 dichlorine multiple interactions ISO RGD:2137 6480464 [Ozone co-treated with Chlorine] results in increased expression of APOD mRNA CTD PMID:18636392 dioxygen decreases response to substance EXP 6480464 APOD protein results in decreased susceptibility to Oxygen deficiency CTD PMID:18458334 diuron decreases expression ISO RGD:2137 6480464 Diuron results in decreased expression of APOD mRNA CTD PMID:25152437 doxorubicin increases expression ISO RGD:10180 6480464 Doxorubicin results in increased expression of APOD mRNA CTD PMID:21040762 , PMID:28608983 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of APOD mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:10180 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of APOD mRNA CTD PMID:21040762 fenvalerate increases expression ISO RGD:2137 6480464 fenvalerate results in increased expression of APOD mRNA CTD PMID:30307764 flavonoids decreases expression ISO RGD:2137 6480464 Flavonoids results in decreased expression of APOD mRNA CTD PMID:18035473 flurbiprofen increases expression ISO RGD:10180 6480464 Flurbiprofen results in increased expression of APOD mRNA CTD PMID:16949054 folic acid increases expression ISO RGD:10180 6480464 Folic Acid results in increased expression of APOD mRNA CTD PMID:25629700 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of APOD mRNA CTD PMID:23649840 fulvestrant increases expression EXP 6480464 fulvestrant results in increased expression of APOD mRNA CTD PMID:16514628 furan increases methylation ISO RGD:2137 6480464 furan results in increased methylation of APOD gene CTD PMID:22079235 genistein increases expression EXP 6480464 Genistein results in increased expression of APOD mRNA CTD PMID:20884965 genistein decreases expression ISO RGD:10180 6480464 Genistein results in decreased expression of APOD mRNA CTD PMID:32186404 haloperidol increases expression ISO RGD:10180 6480464 Haloperidol results in increased expression of APOD mRNA CTD PMID:14647396 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of APOD mRNA CTD PMID:28628672 isoprenaline increases expression ISO RGD:10180 6480464 Isoproterenol results in increased expression of APOD mRNA CTD PMID:20003209 medroxyprogesterone acetate increases expression EXP 6480464 Medroxyprogesterone Acetate results in increased expression of APOD mRNA CTD PMID:20843944 methamphetamine decreases expression ISO RGD:2137 6480464 Methamphetamine results in decreased expression of APOD mRNA CTD PMID:28619521 methapyrilene increases methylation EXP 6480464 Methapyrilene results in increased methylation of APOD intron CTD PMID:30157460 methotrexate affects expression ISO RGD:10180 6480464 Methotrexate affects the expression of APOD mRNA CTD PMID:18502557 methylseleninic acid affects expression EXP 6480464 methylselenic acid affects the expression of APOD mRNA CTD PMID:14617803 monosodium L-glutamate multiple interactions ISO RGD:10180 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of APOD mRNA CTD PMID:19001666 monosodium L-glutamate increases expression ISO RGD:10180 6480464 Sodium Glutamate results in increased expression of APOD mRNA CTD PMID:20111022 naphthalene increases expression ISO RGD:10180 6480464 naphthalene results in increased expression of APOD mRNA CTD PMID:18978301 nickel atom affects binding EXP 6480464 APOD protein binds to Nickel CTD PMID:23896426 nitrofen decreases expression ISO RGD:2137 6480464 nitrofen results in decreased expression of APOD mRNA CTD PMID:33484710 ozone multiple interactions ISO RGD:2137 6480464 [Ozone co-treated with Chlorine] results in increased expression of APOD mRNA CTD PMID:18636392 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of APOD mRNA CTD PMID:19682730 paraquat increases expression EXP 6480464 Paraquat results in increased expression of APOD mRNA, Paraquat results in increased expression of APOD protein CTD PMID:21688324 paraquat decreases response to substance ISO RGD:10180 6480464 APOD protein results in decreased susceptibility to Paraquat CTD PMID:18419796 paraquat increases expression ISO RGD:10180 6480464 Paraquat results in increased expression of APOD mRNA CTD PMID:18419796 paraquat decreases response to substance EXP 6480464 APOD protein results in decreased susceptibility to Paraquat CTD PMID:18458334 , PMID:21688324 paraquat multiple interactions EXP 6480464 Paraquat results in increased uptake of and affects the localization of APOD protein more ... CTD PMID:21688324 , PMID:28182653 paraquat affects response to substance ISO RGD:10180 6480464 APOD protein affects the susceptibility to Paraquat CTD PMID:21688324 paraquat multiple interactions ISO RGD:10180 6480464 [APOD protein affects the susceptibility to Paraquat] which affects the expression of PRKCD mRNA more ... CTD PMID:21463325 more ... PCB138 multiple interactions ISO RGD:10180 6480464 [2 more ... CTD PMID:25510870 phencyclidine increases expression ISO RGD:10180 6480464 Phencyclidine results in increased expression of APOD mRNA CTD PMID:17266109 progesterone multiple interactions EXP 6480464 [Progesterone co-treated with Estradiol] results in increased expression of APOD mRNA CTD PMID:17404688 progesterone increases expression EXP 6480464 Progesterone results in increased expression of APOD mRNA CTD PMID:17404688 more ... propanal increases expression EXP 6480464 propionaldehyde results in increased expression of APOD mRNA CTD PMID:26079696 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of APOD mRNA CTD PMID:16514628 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of APOD mRNA CTD PMID:25895662 sirolimus affects localization EXP 6480464 Sirolimus affects the localization of APOD protein CTD PMID:28182653 testosterone decreases expression ISO RGD:10180 6480464 Testosterone results in decreased expression of APOD mRNA CTD PMID:19693291 testosterone multiple interactions ISO RGD:2137 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of APOD mRNA CTD PMID:32741896 trichostatin A multiple interactions EXP 6480464 [decitabine co-treated with trichostatin A] affects the expression of APOD mRNA CTD PMID:16865689 trimellitic anhydride decreases expression ISO RGD:10180 6480464 trimellitic anhydride results in decreased expression of APOD mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:10180 6480464 triptonide results in increased expression of APOD mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:10180 6480464 troglitazone results in increased expression of APOD mRNA CTD PMID:28973697 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of APOD gene CTD PMID:29154799 valproic acid increases expression ISO RGD:2137 6480464 Valproic Acid results in increased expression of APOD mRNA CTD PMID:23665938 vincristine increases expression EXP 6480464 Vincristine results in increased expression of APOD mRNA CTD PMID:23649840 vinyl carbamate decreases expression ISO RGD:10180 6480464 vinyl carbamate results in decreased expression of APOD mRNA CTD PMID:17849452
